Cancer Home > Erlotinib
Clinical EffectsIn clinical studies, erlotinib has been shown to improve survival in people with NSCLC and pancreatic cancer. In one study, 31 percent of people who took erlotinib for advanced NSCLC were still alive after one year of treatment, compared with 22 percent of people with NSCLC who took a placebo (a "sugar" pill with no active ingredients).
- This medication comes in tablet form. It is normally taken by mouth once a day.
- Erlotinib should be taken on an empty stomach at least one hour before or two hours after food.
- Do not drink grapefruit juice or eat grapefruit while taking this medicine.
- Try to take your dose at the same time each day to keep an even level of the drug in your bloodstream.
- For erlotinib to work properly, it must be taken as prescribed.
- Why you are using the medication
- How well you tolerate it
- Other medical conditions you may have
- Other medications you are taking.